BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38310415)

  • 1. 14-3-3η Proteins as a Diagnostic Marker, Disease Activation Indicator, and Lymphoma Predictor in Patients with Primary Sjögren Syndrome.
    Kor A; Yalçın M; Erten Ş; Maraş Y; Oğuz EF; Doğan İ; Atalar E; Başer S; Erel Ö
    Arch Iran Med; 2023 Oct; 26(10):582-591. PubMed ID: 38310415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A lower prevalence of malignant lymphoma in Sjögren's syndrome patients: A cross-sectional study.
    Saleh W; Elashry MM; Winn N; Mona M; Katz J; Cha S
    Oral Dis; 2023 Nov; 29(8):3313-3324. PubMed ID: 36369668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Sjögren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development.
    Goules AV; Argyropoulou OD; Pezoulas VC; Chatzis L; Critselis E; Gandolfo S; Ferro F; Binutti M; Donati V; Zandonella Callegher S; Venetsanopoulou A; Zampeli E; Mavrommati M; Voulgari PV; Exarchos T; Mavragani CP; Baldini C; Skopouli FN; Fotiadis DI; De Vita S; Moutsopoulos HM; Tzioufas AG
    Front Immunol; 2020; 11():594096. PubMed ID: 33193443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome.
    Solans-Laqué R; López-Hernandez A; Bosch-Gil JA; Palacios A; Campillo M; Vilardell-Tarres M
    Semin Arthritis Rheum; 2011 Dec; 41(3):415-23. PubMed ID: 21665245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features distinguishing lymphoma development in primary Sjögren's Syndrome--a retrospective cohort study.
    Risselada AP; Kruize AA; Bijlsma JW
    Semin Arthritis Rheum; 2013 Oct; 43(2):171-7. PubMed ID: 23664530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation of disease activity in Sjögren's syndrome based on the degree of MALT involvement: glandular swelling and cryoglobulinaemia compared to ESSDAI in a cohort study.
    De Vita S; Gandolfo S; Zandonella Callegher S; Zabotti A; Quartuccio L
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):150-156. PubMed ID: 30156548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic role of CXCL13 biomarker in primary Sjogren's syndrome patients with parotid non-Hodgkin's lymphoma complication.
    Badarinza M; Serban O; Maghear L; Pelea MA; Rosca RI; Fodor D; Stancu B
    Med Clin (Barc); 2023 Jun; 160(11):484-488. PubMed ID: 37005121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryoglobulinemia in Sjögren Syndrome: A Disease Subset that Links Higher Systemic Disease Activity, Autoimmunity, and Local B Cell Proliferation in Mucosa-associated Lymphoid Tissue.
    Quartuccio L; Baldini C; Priori R; Bartoloni E; Carubbi F; Alunno A; Gandolfo S; Colafrancesco S; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S;
    J Rheumatol; 2017 Aug; 44(8):1179-1183. PubMed ID: 28507188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects.
    Baimpa E; Dahabreh IJ; Voulgarelis M; Moutsopoulos HM
    Medicine (Baltimore); 2009 Sep; 88(5):284-293. PubMed ID: 19745687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The relationship between Sjogren's syndrome, systemic sclerosis and lymphoproliferative diseases].
    Vasil'ev VI; Chal'tsev BD; Gorodetskii VR; Pal'shina SG; Shornikova NS; Anan'eva LP; Gaiduk IV; Kokosadze NV; Probatova NA; Pavlovskaia AI; Rodionova EB; Safonova TN; Balabina AA
    Ter Arkh; 2020 Dec; 92(12):126-136. PubMed ID: 33720584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease activity and damage in patients with primary Sjogren's syndrome: Prognostic value of salivary gland ultrasonography.
    Milic V; Colic J; Cirkovic A; Stanojlovic S; Damjanov N
    PLoS One; 2019; 14(12):e0226498. PubMed ID: 31891590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for cardiovascular disease in primary Sjögren's syndrome (pSS): a 20-year follow-up study.
    Santos CS; Salgueiro RR; Morales CM; Castro CÁ; Álvarez ED
    Clin Rheumatol; 2023 Nov; 42(11):3021-3031. PubMed ID: 37402929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early prediction of severe COVID-19 in patients with Sjögren's syndrome].
    Li JB; Lyu MN; Chi Q; Peng YL; Liu PC; Wu R
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1007-1012. PubMed ID: 38101781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome.
    Chen C; Liang Y; Zhang Z; Zhang Z; Yang Z
    Int Immunopharmacol; 2020 Nov; 88():106878. PubMed ID: 32791244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical picture, outcome and predictive factors of lymphoma in primary Sjögren's syndrome: results from a harmonized dataset (1981-2021).
    Chatzis LG; Stergiou IE; Goules AV; Pezoulas V; Tsourouflis G; Fotiadis D; Tzioufas AG; Voulgarelis M
    Rheumatology (Oxford); 2022 Aug; 61(9):3576-3585. PubMed ID: 34940812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-center, open-label, randomized study to explore efficacy and safety of baricitinib in active primary Sjogren's syndrome patients.
    Bai W; Yang F; Xu H; Wei W; Li H; Zhang L; Zhao Y; Shi X; Zhang Y; Zeng X; Leng X
    Trials; 2023 Feb; 24(1):112. PubMed ID: 36793118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of faecal calprotectin in primary Sjögren's syndrome is common and associated with concomitant organic gastrointestinal disease.
    Andréasson K; Ohlsson B; Mandl T
    Arthritis Res Ther; 2016 Jan; 18():9. PubMed ID: 26759247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity.
    Mandl T; Marsal J; Olsson P; Ohlsson B; Andréasson K
    Arthritis Res Ther; 2017 Oct; 19(1):237. PubMed ID: 29065905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum 14-3-3η protein is associated with clinical and serologic features of Sjögren's syndrome in patients with systemic lupus erythematosus: a cross-sectional analysis.
    Hammam N; Gamal NM; Elzohri MH; Elsonbaty AM; Rashed AM; Eldaly ZH; Tarik D; Gheita TA
    Clin Rheumatol; 2020 Sep; 39(9):2603-2610. PubMed ID: 32206972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing hand and wrist ultrasound pattern in primary Sjögren's syndrome: a case-control study.
    Guedes LKN; Leon EP; Bocate TS; Bonfigliolli KR; Lourenço SV; Bonfa E; Pasoto SG
    Clin Rheumatol; 2020 Jun; 39(6):1907-1918. PubMed ID: 32072351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.